HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Heyman Luckraz Sue Taylor Vincenzo Argano Aprim Youhana Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Luckraz, H. Articles by Youhana, A. Search for Related Content PubMed PubMed Citation Articles by Luckraz, H. Articles by Youhana, A. Related Collections Cardiac - other

Eur J Cardiothorac Surg 2005;27:906-909
© 2005 Elsevier Science NL

Long and short-term outcomes in patients requiring continuous renal replacement therapy post cardiopulmonary bypass

^a Cardiothoracic Unit, Morriston Hospital, Swansea SA6 6NL, UK
^b The Clinical School (Statistics), University of Wales Swansea, Swansea SA2 8PP, UK
^c Renal Unit, Morriston Hospital, Swansea SA6 6NL, UK

Received 9 September 2004; received in revised form 17 January 2005; accepted 20 January 2005.

^* Corresponding author. Tel.: +44 1792 702222; fax: +44 1792 703242. (E-mail: heymanluckraz{at}aol.com).

	Abstract

Top Abstract 1. Introduction 2. Methods 3. Statistics 4. Results 5. Comment 6. Conclusion References

 
Objective: The development of acute renal failure following cardiac surgery is a rare but devastating complication with high morbidity and mortality. This study aimed to assess the incidence of acute renal failure necessitating continuous renal replacement therapy (CRRT) in patients who required cardiopulmonary bypass, to determine the factors associated with mortality and to evaluate long-term outcome. Methods: Patients who underwent cardiac surgery between October 1997 and 2003 and treated with CRRT were included (n=98). Six patients were then excluded (already in established renal failure pre-operatively) and one patient lost to follow-up. A retrospective analysis was carried out. Results: Overall CRRT was used in 2.9% (92/3172). The mean (SD) age of patients was 68 (10) years. Their mean pre-operative creatinine level and duration of cardiopulmonary bypass were 154 (87)micromol/l and 160 (84)min, respectively. Mean duration from surgery to establishment of CRRT was 50 (42)h. Mean creatinine level prior to hospital discharge was 168 (93)micromol/l. Thirty-day mortality was 42%. Significant risk factors for death were complex procedures (odds ratio=9.9), gastro-intestinal complications (OR=7.2), cross-clamp time over 88min (OR=5.9), re-exploration (OR=4.0) and patients age over 75 years (OR=3.3). Actuarial 1 and 5-year survivals (95% CI) were 53 (43, 63) % and 52 (42, 62) %, respectively. Only 2 (2.2%) patients required long term renal support. Conclusions: Acute renal failure necessitating the use of CRRT is a rare but serious complication post cardiopulmonary bypass. In the long-term, surviving patients are not likely to require further renal support.

Key Words: Renal replacement therapy • Cardiopulmonary bypass

	1. Introduction

Top Abstract 1. Introduction 2. Methods 3. Statistics 4. Results 5. Comment 6. Conclusion References

 
Acute renal failure (ARF) necessitating the use of continuous renal replacement therapy (CRRT) is a rare but devastating complication of cardiac surgery. Its incidence is reported to be to vary from 2 to 15% [1] with an associated mortality of 40–80% [2]. The risk factors predisposing to this complication include pre-operative renal dysfunction, age, vascular disease, emergency surgery and re-operations [3]. Moreover, Chertow et al. have shown that ARF is an independent predictor of mortality in cardiac surgery [4].

ARF is linked to multiple post-operative complications leading to prolonged hospitalisation and increased costs.

However, for patients who survive this complication, the need for long term renal replacement therapy is rare compared to patients who develop acute renal failure from other causes [5].

We reviewed the need for CRRT in our population group and assessed the morbidity and mortality in the short and long term.

	2. Methods

Top Abstract 1. Introduction 2. Methods 3. Statistics 4. Results 5. Comment 6. Conclusion References

 
All patients who underwent cardiac surgical procedures (from Oct 1997 to Oct 2003) and developed ARF with the need for CRRT were initially included in this study (n=98). Six patients were then excluded as they were in established chronic renal failure pre-operatively and were being haemofiltered. One patient was lost to long-term follow-up.

Data were retrospectively collected from patients' records and their intensive care management charts. Patients' status (alive or dead) was first confirmed using the hospital-based electronic database. Patients who were alive, were contacted through a telephone call to get an update on their renal condition. One patient was not contactable having moved out of the region.

The need for haemofiltration was confirmed by the renal physician and the indications included fluid management, acidosis and/or hyperkalaemia. The CRRT was instituted by the renal nursing staff. Vascular access was via a central vein with a dual lumen polyurethane catheter (Joka Kathetertechnik, 72379, Hechingen, Germany). Three Braun Trio pumps (Schwarzenbergen, Melsungen, Germany) were used. The dialysate fluid used (Monosol, Monosol K: Baxter, Thetford, UK, and Hemosol BO: Hospal International, Marketing Management S.N.C, Lyon, France) depended on the patients' electrolytes. Filtration was achieved through a Fresenius polysulfone filter (ultraflux AV 400S, 0.75m², Fresenius Medical care AG, Badmonberg). Patients were anticoagulated with heparin maintaining an ACT (activated clotting time) of 180–200s. According to nomenclature for CRRT described by Bellomo et al. [6], the principle method of solute removal was by diffusion.

	3. Statistics

Top Abstract 1. Introduction 2. Methods 3. Statistics 4. Results 5. Comment 6. Conclusion References

 
Data were analysed using the SPSS and R statistical systems. Results are expressed as mean (SD), median (IQR) or percentages with 95% confidence intervals, where appropriate. Risk factors for fatal outcome were calculated using binary logistic regression. Data were available for the following potential risk factors: gender, age, ejection fraction, myocardial infarction, diabetes mellitus, hypertension, peripheral vascular disease, pre-operative creatinine levels, redo-surgery, operation type, operation timing, cardiopulmonary bypass and cross clamp times, re-exploration for bleeding, inotropic support, sepsis, wound infection, chest infection, the need for tracheostomy, gastro-intestinal and neurological complications. A final model for risk factors was obtained using a forward stepwise selection procedure. At each step the factor that lead to the greatest change in deviance for the model fit (and significant at the 5% level) was added to the model. Factors were retained in the model at subsequent steps if they remained significant at least at the 10% level, combined with an odds ratio of at least 2. Care was taken to examine the contribution of variables together, when a high degree of correlation was known between them (for example cardiopulmonary bypass and cross clamp times and operation type). Lastly, all 2-way interactions between variables in the final model were examined. All odds ratios reported below are adjusted for the factors in the final model. Survival analysis was carried out with the Kaplan–Meier survival curve.

	4. Results

Top Abstract 1. Introduction 2. Methods 3. Statistics 4. Results 5. Comment 6. Conclusion References

 
Overall CRRT was used in 2.9% (92/3172) of patients undergoing cardiac surgery.

The mean age of the patients was 68 (10) years with 67% being males. Peripheral vascular disease was diagnosed in 9% of patients and 13% underwent redo-surgery. The left ventricular function was impaired (EF<50%) in 64% while in only 27% the surgery was carried out electively with 48% being urgent and 25% emergencies.

The mean pre-operative creatinine level was 154 (87)micromol/l. Isolated coronary artery bypass surgery (CABG) was performed in 34% of patients and CABG was combined with valvular surgery in 34%. Mean duration of cardiopulmonary bypass was 160 (84)min. The creatinine level prior to establishment of haemofiltration was 295 (89)micromol/l. The mean duration from surgery to haemofiltration was 50 (42)h and the renal replacement therapy was used for 6.4 (5.5) days.

Sepsis developed in 43% of patients during their ICU stay. A tracheostomy for assisting prolonged ventilatory support was performed in 32% and 40% required mechanical inotropic support with the intra-aortic balloon pump. Neurological and gastrointestinal complications were recorded in 14% and 16% of patients, respectively.

The median stay in intensive care was 10 (6, 18) days. The 30-day mortality was 42%.

Median in-hospital stay for the survivors was 21 (15, 37) days.

The mean creatinine level prior to hospital discharge was 168 (93)micromol/l. Only 2 (2.2%) patients required long term renal replacement therapy.

Significant risk factors for death (Table 1) were complex (redo, CABG+Valve, double valve, aortic surgery) procedures (OR=9.9), gastro-intestinal complications (OR=7.2), cross-clamp time over 88min (OR=5.9), re-exploration for bleeding (OR=4.0) and patients age over 75 years (OR=3.3). There was an indication that the effect of cross-clamp time on mortality was greater for patients with gastrointestinal complications.

View larger version (16K): [in this window] [in a new window]   Fig. 1. Estimated survivorship curve (with 95% confidence limits) for cardiac surgery patients following acute renal failure. Most deaths occurred during the first 20 days post-operation, with the 75% survival time being 7 days (4, 14).

	5. Comment

Top Abstract 1. Introduction 2. Methods 3. Statistics 4. Results 5. Comment 6. Conclusion References

Several mechanisms have been postulated for the occurrence of ARF. Hypo-perfusion of the renal medulla seems to be the most likely mechanism leading to ARF. This pathological process is due to vasoconstriction of the renal arterioles leading to redistribution of blood flow within the kidneys with under-perfusion in certain areas [11]. Reduction in renal blood flow has been demonstrated to be worse prior to rather than during CPB [12]. Prolonged renal arteriolar vasoconstriction is perpetuated by hypovolaemia, dehydration, increased levels of vasoconstrictors (vasopressin, angiotensin, aldosterone, cathecolamines, thromboxanes) as well as a decrease in atrial natriuretic peptide (ANP) and nitric oxide (NO) levels [13]. Moreover, renal damage may be precipitated when the kidneys are exposed to nephrotoxic agents (aminoglycosides, vancomycin, contrast dye) in the immediate pre-operative period. In the heart transplant setting, calcineurin inhibitors have been implicated in the development of renal damage [14]. Other factors which may play a role in the development of ARF post CPB include tissue oedema [15], micro-embolisation [16], endothelial dysfunction [17] and the generalised inflammatory response as a consequence of the CPB circuit [18].

The incidence of ARF has not decreased despite attempts to reverse the patho-physiological processes involved. The most important preventive step includes adequate re-hydration (normovolaemia) and maintenance of acceptable cardiac output.

When renal failure is established, fluid management, hyperkalaemia and acidosis remain the main indications for haemofiltration. The end result is an improvement in cardiac contractility which has been reported to be due to the elimination of myocardial depressant factor and cytokines [19]. This is better achieved by continuous renal replacement therapy than intermittent haemodialysis.

Lango et al. reported an 86% functional recovery but a 30% in-hospital mortality with high-volume (50–80ml/min) continuous renal replacement therapy [19]. Bent et al. reported a 40% mortality with early and intensive continuous renal replacement therapy (2000ml/h) [10]. The mean duration for CRRT was 3.98 (3.00, 4.97) days. There is evidence to suggest that a lower mortality is achievable with CRRT use if it is instituted early. An 80% mortality was reported when continuous renal replacement therapy was instituted over a week post-operatively [20]. In our patient group, the renal replacement therapy was instituted within 2 days of the surgical procedure and the filtration rate was set at 1000ml/h. The in-hospital mortality was 42% despite the setting of an older population group (mean age 68 years) and sicker patients (impaired LV function in 64% and elective surgery in only 27%). Similar experience was reported by Elahi et al. [21].

The long-term outlook in patients who survive this serious complication is relatively very good. Only two patients (2.2%) required long term continuous renal replacement therapy. In a prospective observational study in Scotland, Metcalfe et al., reported an ARF (all causes) incidence of 375 patients per million [5] with an 90-day mortality of 73.5 and 23.5% becoming dependent of renal replacement therapy due to end-stage renal dysfunction (ESRD). In the post CPB setting, few patients end up with ESRD probably reflecting the reversibility of the damage to the kidneys. Moreover, the long term survival (5 years) was as good as the early survival rate (1 year).

	6. Conclusion

Top Abstract 1. Introduction 2. Methods 3. Statistics 4. Results 5. Comment 6. Conclusion References

 
Renal replacement therapy (CVVHF) was needed in a small percentage of patients undergoing cardiac surgery. Their use was associated with a high morbidity and mortality. However, the long term outlook was excellent in patients who survived this onslaught.

	References

Top Abstract 1. Introduction 2. Methods 3. Statistics 4. Results 5. Comment 6. Conclusion References

 

1. Sirivella S, Gielchinsky I, Parsonnet V. Mannitol, furosemide and dopamine infusion in post-operative renal failure complicating cardiac surgery. Ann Thorac Surg 2000;69:501-506.[Abstract/Free Full Text]
2. Lassnigg A, Donner E, Grubhofer G, Presterl E, Druml W, Hiesmayr M. Lack of reno-protective effects of dopamine and furosemide during cardiac surgery. J Am Soc Nephrol 2000;11:97-104.[Abstract/Free Full Text]
3. Chertow GM, Lazarus JM, Christianses CL, Cook EF, Hammermeister KE, Grover F, Daley J. Preoperative renal risk stratification. Circulation 1997;95:878-884.[Abstract/Free Full Text]
4. Chertow GM, Levy EM, Hammermeister KE, Grover F, Daley J. Independent association between acute renal failure and mortality following cardiac surgery. Am J Med 1998;104:343-348.[CrossRef][Medline]
5. Metcalfe W, Simpson M, Prescott GJ, Simpson K, Smith WCS, MacLeod AM. Acute renal failure requiring renal replacement therapy: incidence and outcome. QJM 2002;95:579-583.[Abstract/Free Full Text]
6. Bellomo R, Ronco C, Mehta RL. Technique of continuous renal replacement therapy: Nomenclature for continuous renal replacement therapies. Am J Kidney Dis 1996;28:S2-S7.[CrossRef]
7. Kellerman PS. Perioperative care of the renal patient. Arch Intern Med 1994;154:1674-1688.[Abstract/Free Full Text]
8. Kramer P, Kaufhold G, Grone HJ, Wigger W, Rieger J, Matthaei D, Stokke T, Burchardi H, Scheler F. Management of anuric intensive care patients with arteriovenous hemofiltration. Int J Artif Organs 1980;3:225-227.[Medline]
9. Frost L, Pedersen RS, Lund O, Hansen OK, Hansen HE. Prognosis and risk factors in acute, dialysis-requiring renal failure after open-heart surgery. Scand J Thorac Cardiovasc Surg 1991;25:161-166.[Medline]
10. Bent P, Tan HK, Bellomo R, Buckmanter J, Doolan L, Hart G, Silvester W, Gutteridge G, Matalanis G, Raman J, Rosalion A, Buxton BF. Early and intensive continuous hemofiltration for severe renal failure after cardiac surgery. Ann Thorac Surg 2001;71:832-837.[Abstract/Free Full Text]
11. De Moreas Lobo EM, Burdmann EA, Abdulkader RCRM. Renal function changes after elective cardiac surgery with cardiopulmonary bypass. Renal Failure 2000;22:487-497.[CrossRef][Medline]
12. Lema G, Meneses G, Urzua J, Jalil R, Canessa R, Moran S, Irarrazaval MJ, Zalaquett R, Orellana P. Effects of extracorporeal circulation on renal function in coronary surgical patients. Anaesth Analg 1995;81:446-451.[Abstract]
13. Sladen R, Prough D. Peri-operative renal protection. Crit Care Clin 1997;9:314-331.
14. Groetzner J, Kaczmarek I, Landwehr P, Mueller M, Daebritz S, Lamm P, Meiser B, Reichart B. Renal recovery after conversion to a calcineurin inhibitor-free immunosuppression in late cardiac transplant recipients. Eur J Cardiothorac Surg 2004;25:333-341.[Abstract/Free Full Text]
15. Amirhamzeh MMR, Dean DA, Jia CX, Cabreriza SE, Starr JP, Sardo MJ, Chalik N, Dickstein ML, Spotnitz HM. Iatrogenic myocardial oedema: increased diastolic compliance and time course of resolution in vivo. Ann Thorac Surg 1996;62:737-743.[Abstract/Free Full Text]
16. Piriou V, Claudel JP, Bastien O, Ross S, Lehot JJ. Severe systemic cholesterol embolisation after open heart surgery. Br J Anaesth 1996;77:277-280.[Abstract/Free Full Text]
17. Verrier DE, Boyle EM. Endothelial cell injury in cardiovascular surgery. Ann Thorac Surg 1996;62:915-922.[Abstract/Free Full Text]
18. Gu YJ, de Vries AJ, Boonstra PW, Van Oeveren W. Leukocyte depletion results in improved lung function and reduced inflammatory response after cardiac surgery. J Thorac Cardiovasc Surg 1996;112:494-500.[Abstract/Free Full Text]
19. Lango R, Rogowski J, Siebert J, Stoutenbeek CP, Oudemans-van Straaten HM, Zandstra DF. Effects of high volume continuous veno-venous hemofiltration in cardiac surgery patients with renal failure. Med Sci Monit 1997;3:813-820.
20. Baudouin SV, Wiggins J, Keogh BF, Morgan CJ, Evans TW. Continuous veno-venous haemofiltration following cardio-pulmonary bypass. Intensive Care Med 1993;19:290-293.[CrossRef][Medline]
21. Elahi MM, Lim MY, Joseph RN, Dhannapuneni RRV, Spyt TJ. Early hemofiltration improves survival in post-cardiotomy patients with acute renal failure. Eur J Cardiothorac Surg 2004;26:1027-1031.[Abstract/Free Full Text]

This article has been cited by other articles:

				S. Vidal, P. Richebe, L. Barandon, J. Calderon, N. Tafer, O. Pouquet, N. Fournet, and G. Janvier Evaluation of continuous veno-venous hemofiltration for the treatment of cardiogenic shock in conjunction with acute renal failure after cardiac surgery Eur. J. Cardiothorac. Surg., September 1, 2009; 36(3): 572 - 579. [Abstract] [Full Text] [PDF]

				C. E. Hobson, S. Yavas, M. S. Segal, J. D. Schold, C. G. Tribble, A. J. Layon, and A. Bihorac Acute Kidney Injury Is Associated With Increased Long-Term Mortality After Cardiothoracic Surgery Circulation, May 12, 2009; 119(18): 2444 - 2453. [Abstract] [Full Text] [PDF]

				M. Elahi, S. Asopa, A. Pflueger, N. Hakim, and B. Matata Acute kidney injury following cardiac surgery: impact of early versus late haemofiltration on morbidity and mortality Eur. J. Cardiothorac. Surg., May 1, 2009; 35(5): 854 - 863. [Abstract] [Full Text] [PDF]

				L. S. De Santo, C. Bancone, G. Santarpino, G. Romano, M. De Feo, M. Scardone, N. Galdieri, and M. Cotrufo Microbiologically documented nosocomial infections after cardiac surgery: an 18-month prospective tertiary care centre report Eur. J. Cardiothorac. Surg., April 1, 2008; 33(4): 666 - 672. [Abstract] [Full Text] [PDF]

				C. Simon, R. Luciani, F. Capuano, A. Miceli, A. Roscitano, E. Tonelli, and R. Sinatra Mild and moderate renal dysfunction: impact on short-term outcome Eur. J. Cardiothorac. Surg., August 1, 2007; 32(2): 286 - 290. [Abstract] [Full Text] [PDF]

				A. Jander, M. Tkaczyk, I. Pagowska-Klimek, W. Pietrzykowski, J. Moll, W. Krajewski, and M. Nowicki Continuous veno-venous hemodiafiltration in children after cardiac surgery Eur. J. Cardiothorac. Surg., June 1, 2007; 31(6): 1022 - 1028. [Abstract] [Full Text] [PDF]

				I. Bahar, A. Akgul, M. A. Ozatik, K. M Vural, A. E Demirbag, M. Boran, and O. Tasdemir Acute renal failure following open heart surgery: risk factors and prognosis Perfusion, December 1, 2005; 20(6): 317 - 322. [Abstract] [PDF]

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Heyman Luckraz Sue Taylor Vincenzo Argano Aprim Youhana Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Luckraz, H. Articles by Youhana, A. Search for Related Content PubMed PubMed Citation Articles by Luckraz, H. Articles by Youhana, A. Related Collections Cardiac - other